Yumanity Therapeutics Inc (YMTX)

4.16 -0.06  -1.42% NASDAQ Nov 29, 16:00 4.16 0.00  0.00% After-Hours: 19:48 USD
View Full Chart
Price Chart
View All YMTX News

News

View All Events

Events

Date Type Description
03/31/2022 Earnings Results Q4 2021 Earnings Results
11/15/2021 Earnings Results Q3 2021 Earnings Results
08/12/2021 Earnings Results Q2 2021 Earnings Results
06/02/2021 09:00 EST AGM 2020 Annual General Meeting
05/13/2021 Earnings Results Q1 2021 Earnings Results
03/31/2021 Earnings Results Q4 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's lead program, YTX-7739, is in phase 1 clinical development for Parkinson's disease.
  • URL: https://www.yumanity.com
  • Investor Relations URL: N/A
  • HQ State/Province: Massachusetts
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: N/A
  • Next Earnings Release: Mar. 31, 2022
  • Last Earnings Release: Nov. 15, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.